Concordia shares surge after report of Blackstone interest: Reuters

U.S. private equity firm Blackstone Group LP is considering a takeover of Canadian drug developer Concordia Healthcare Corp, Reuters reported, citing a story by Bloomberg. The talks are at an early stage and a deal may not happen, Bloomberg said. Last year, Concordia acquired London, U.K.-based Amdipharm Mercury Ltd for US$3.3 billion. The deal gave Amdipharm backer Cinven, a European private equity firm, a minority interest in Concordia.

DealsCanadaNorth AmericaBriefs